Literature DB >> 25877541

In vivo radiobiological assessment of the new clinical carbon ion beams at CNAO.

A Facoetti1, B Vischioni2, M Ciocca2, M Ferrarini2, Y Furusawa3, A Mairani2, Y Matsumoto3, A Mirandola2, S Molinelli2, A Uzawa3, Freixas G Vilches2, R Orecchia4.   

Abstract

In this article, the in vivo study performed to evaluate the uniformity of biological doses within an hypothetical target volume and calculate the values of relative biological effectiveness (RBE) at different depths in the spread-out Bragg peak (SOBP) of the new CNAO (National Centre for Oncological Hadrontherapy) carbon beams is presented, in the framework of a typical radiobiological beam calibration procedure. The RBE values (relative to (60)Co γ rays) of the CNAO active scanning carbon ion beams were determined using jejunal crypt regeneration in mice as biological system at the entrance, centre and distal end of a 6-cm SOBP. The RBE values calculated from the iso-effective doses to reduce crypt survival per circumference to 10, ranged from 1.52 at the middle of the SOBP to 1.75 at the distal position and are in agreement with those previously reported from other carbon ion facilities. In conclusion, this first set of in vivo experiments shows that the CNAO carbon beam is radiobiologically comparable with the NIRS (National Institute of Radiological Sciences, Chiba, Japan) and GSI (Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany) ones.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25877541     DOI: 10.1093/rpd/ncv145

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  6 in total

1.  Uptake of 18F-FET and 18F-FCH in Human Glioblastoma T98G Cell Line after Irradiation with Photons or Carbon Ions.

Authors:  Francesca Pasi; Marco Giovanni Persico; Federica Eleonora Buroni; Carlo Aprile; Marina Hodolic; Franco Corbella; Rosanna Nano; Angelica Facoetti; Lorenzo Lodola
Journal:  Contrast Media Mol Imaging       Date:  2017-01-16       Impact factor: 3.161

2.  A New Platinum-Based Prodrug Candidate for Chemotherapy and Its Synergistic Effect With Hadrontherapy: Novel Strategy to Treat Glioblastoma.

Authors:  Beatrice Ferrari; Elisa Roda; Erica Cecilia Priori; Fabrizio De Luca; Angelica Facoetti; Mauro Ravera; Federico Brandalise; Carlo Alessandro Locatelli; Paola Rossi; Maria Grazia Bottone
Journal:  Front Neurosci       Date:  2021-03-22       Impact factor: 4.677

3.  Brainstem NTCP and Dose Constraints for Carbon Ion RT-Application and Translation From Japanese to European RBE-Weighted Dose.

Authors:  Jon Espen Dale; Silvia Molinelli; Barbara Vischioni; Viviana Vitolo; Maria Bonora; Giuseppe Magro; Andrea Mairani; Azusa Hasegawa; Tatsuya Ohno; Olav Dahl; Francesca Valvo; Piero Fossati
Journal:  Front Oncol       Date:  2020-11-24       Impact factor: 6.244

4.  Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy.

Authors:  Barbara Vischioni; Stefania Russo; Martino Meuli; Maria Bonora; Sara Ronchi; Rossana Ingargiola; Anna Maria Camarda; Sara Imparato; Lorenzo Preda; Mario Ciocca; Silvia Molinelli; Ester Orlandi
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244

5.  Surgical spacer placement prior carbon ion radiotherapy (CIRT): an effective feasible strategy to improve the treatment for sacral chordoma.

Authors:  Cobianchi Lorenzo; Peloso Andrea; Vischioni Barbara; Panizza Denis; Fiore Maria Rosaria; Fossati Piero; Vitolo Viviana; Iannalfi Alberto; Ciocca Mario; Silvia Brugnatelli; Dominioni Tommaso; Dario Bugada; Maestri Marcello; Alessiani Mario; Valvo Francesca; Orecchia Roberto; Dionigi Paolo
Journal:  World J Surg Oncol       Date:  2016-08-09       Impact factor: 2.754

6.  First experimental proof of Proton Boron Capture Therapy (PBCT) to enhance protontherapy effectiveness.

Authors:  G A P Cirrone; L Manti; D Margarone; G Petringa; L Giuffrida; A Minopoli; A Picciotto; G Russo; F Cammarata; P Pisciotta; F M Perozziello; F Romano; V Marchese; G Milluzzo; V Scuderi; G Cuttone; G Korn
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.